An 'insane' calculus: A pharma company raised price for a rare disease drug 150% to cover Medicaid rebates - statnews.com
A pharma company raised the price for a rare disease drug by 150%, arguing a new U.S. law left it no other choice.
Search Group
Share To
Comments
About Screade
Screade® Inc. version f7eb701, copyright 2016 - 2025
Blocked Users
Customize Dark Theme
Forgot your password?
Forgot your password?
Invite your friends
Please type emails of people you want to invite, we will send them invitation email on your behalf. Separate emails with comma if you want to invite multiple friends.
Comments